Microsoft and Epic Expand Partnership: Generative AI Integration in Healthcare to Alleviate Workforce Burnout and Staff Shortages
Microsoft and Epic are extending their partnership to incorporate AI technologies in the healthcare sector. This joint venture aims to [...]
Target RWE to Showcase Innovative Epidemiology Research and Launch Syndicated Science™ Insights
Target RWE, a leader in real-world evidence, will present innovative research in epidemiology and statistics at the International Society for [...]
Boehringer Ingelheim Files Lawsuit Against U.S. Government Over Medicare’s Drug Price Negotiation Power
Boehringer Ingelheim has filed a lawsuit against the U.S. government, arguing that Medicare's new power to negotiate drug prices is [...]
Bruker to Acquire PhenomeX for $108M
Bruker Corporation is actively acquiring PhenomeX in a cash deal valued at $108 million. PhenomeX, a product of Berkeley Lights' [...]
Advancements in Healthcare: The Influential Roles of Artificial Intelligence and Data Science
The last decade in healthcare has seen notable advancements due to artificial intelligence (AI), particularly data science. By using data-driven [...]
Preliminary Data Suggests Moderna’s Updated Covid-19 Vaccine Effective Against Expected Fall Variants
Moderna's preliminary data suggests that its updated COVID-19 vaccine can effectively combat expected variants this fall, including Eris and Fornax. [...]
Strategic Planning, Partnerships, and Compliance in Conflict Zones
Here's What You Need to Know: The PwC 25th Annual Global CEO Survey showed that geopolitical conflicts significantly threaten global [...]
FDA Approves Ipsen’s Ultra-Rare Bone Disease Drug Sohonos
The Food and Drug Administration (FDA) has approved Ipsen Pharmaceuticals' Sohonos, a drug designed to treat fibrodysplasia ossificans progressiva (FOP), [...]
Japanese Government Funds Arcturus Therapeutics with $115M for mRNA Vaccine Production Expansion
San Diego's RNA biotech firm, Arcturus Therapeutics, has received a $115 million grant from the Japanese government for its manufacturing [...]
FDA to Decide on Bluebird Bio’s Gene Therapy for Sickle Cell Disease
Bluebird Bio's gene therapy for Sickle Cell Disease (SCD), lovotibeglogene autotemcel (lovo-cel), is awaiting FDA approval, with the decision expected [...]
Federal Appeals Court Restricts Access to Abortion Pill Mifepristone
A federal appeals court has ruled to restrict access to the abortion pill mifepristone but has not removed it from [...]
Updates to Keep an Eye on
The FDA has fast-tracked approval of Pfizer's Elfrexfio drug for hard-to-treat multiple myeloma, offering new hope to patients. State and [...]
Genentech to Pay $158,208 for Environmental Violations
Genentech has agreed to pay a $158,208 fine to the U.S. Environmental Protection Agency (EPA) over environmental violations at its [...]
Rising Biotech Stocks: Key Players to Monitor
10 Things You Need to Know: Biotech stocks continue to prosper long-term despite periodic fluctuations. In 2020, prominent biotech companies [...]
Segmed Exceeds 100 Million Imaging Studies Milestone on Its Network
Segmed, a company that focuses on simplifying access to real-world medical imaging data (RWiD), has announced its network has surpassed [...]
Biopharma Companies Plan of Attack After COVID-19 Revenue Boom
The COVID era created new mass-market drugs and vaccines requiring substantial investments. However, investors and analysts urge companies to adapt [...]
Supreme Court Halts Purdue Pharma’s Bankruptcy Plan Worth Billions
The Supreme Court has ordered a temporary halt on the proposed bankruptcy plan for Purdue Pharma, [...]
Skepticism Surrounds NIH’s Long Covid Clinical Trials
The National Institutes of Health (NIH) initiated clinical trials for long Covid – persistent symptoms following [...]
Act4Biosimilars Advocacy Group Strives to Boost Global Adoption of Biosimilars by 2030
Act4Biosimilars, a global biosimilar advocacy initiative, aims to increase global adoption of biosimilars by at least [...]
BioMarin’s Voxzogo Sales Forecast Rises Despite Supply Constraints
Voxzogo's success is posing challenges for BioMarin. Here's what you need to know: BioMarin's drug, Voxzogo, is performing better than [...]
FDA Accelerates Review of HuidaGene’s Treatment for Inherited Blindness
The US Food and Drug Administration (FDA) has granted HuidaGene Therapeutics a rare pediatric disease designation (RPDD) to accelerate the [...]
AI’s Impact and Challenges in the Medical Device and Pharmaceutical Industries
AI and technologies such as computer vision are profoundly influencing the medical device and pharmaceutical industries by bolstering safety, efficiency, [...]
Potential and Challenges of Blockchain Technology in Healthcare
Blockchain, a distributed ledger technology known for supporting cryptocurrencies, has garnered interest in the healthcare sector due to its ability [...]
U.S. Physicians Earn $350K Average; Study Reveals Impact on Overall System Costs
The average U.S. physician earns $350,000 annually, with top doctors making ten times that amount. A study using tax records [...]
Market-Access Firms: The Coveted Target in Healthcare Industry M&A Trend
Market-access firms have become primary takeover targets in the healthcare industry as they are one of the most sought-after subsegments [...]